Table 2.
Characteristics of patients based on the modality of infiltration.
| Monotherapy (N = 56) | Combination (N = 74) | p | |
|---|---|---|---|
| Age | 36.7 (SD 1.7) | 34.6 (SD 1.5) | 0.37 |
| Sex (female:male) | 1:3 | 27:47 | 0.16 |
| Hurley I | 33.93% (19) | 21.62% (16) | 0.0006 |
| II | 62.5% (35) | 48.65% (36) | |
| III | 3.57% (2) | 29.73% (22) | |
| Baseline IHS4 | 4.6 (SD 0.5) | 6.6 (SD 0.4) | 0.009 |
| Baseline NRS pain | 4.9 (SD 0.4) | 4.9 (SD 0.3) | 0.9 |
| Baseline PRS | 4.9 (SD 0.3) | 5.09 (SD 0.3) | 0.8 |
| Total infiltrated nodules | 0.46 (SD 0.11) | 0.14 (SD 0.1) | 0.04 |
| Total infiltrated abscesses | 1.14 (SD 0.1) | 1.16 (SD 0.1) | 0.9 |
| Total infiltrated fistulas | 0.3 (SD 0.09) | 0.58 (SD 0.07) | 0.02 |
Combination, infiltrations in combination with systemic treatments; IHS4, International Hidradenitis Suppurativa Severity Scoring System; Monotherapy, infiltrations in monotherapy; NRS, Numeric rating scale; PRS, patient reported severity; SD, standard deviation.